Steroid medication for allergies — more precisely, corticosteroids — is one of the most effective treatments available for managing allergic conditions such as hay fever, eczema, and allergic asthma. Available in several formulations including nasal sprays, creams, inhalers, and tablets, these medicines work by reducing the underlying inflammation that drives allergic symptoms. Recommended within NHS and NICE clinical guidelines, corticosteroids are well-established, regulated medicines when used correctly. This article explains how they work, which types are available in the UK, how to use them safely, and what side effects to be aware of.

How steroid medications work to relieve allergic symptoms

Steroid medications — more precisely known as corticosteroids — work by mimicking the action of naturally occurring hormones produced by the adrenal glands. When the immune system encounters an allergen such as pollen, dust mites, or animal dander, it triggers an inflammatory response that causes familiar symptoms including sneezing, itching, swelling, and congestion. Corticosteroids intervene at a cellular level by binding to glucocorticoid receptors, which alters gene transcription and leads to a reduction in inflammatory cells such as eosinophils and mast cells, and a downregulation of pro-inflammatory mediators including cytokines, leukotrienes, and prostaglandins. This broad anti-inflammatory action makes them particularly effective at reducing the underlying inflammation that drives allergic reactions.

Unlike antihistamines, which primarily block the effects of histamine after it has been released, corticosteroids modulate the wider inflammatory response. This means they are especially useful for persistent or moderate-to-severe allergic conditions where antihistamines alone may not provide sufficient relief. Their effects are not immediate — intranasal corticosteroids, for example, may take several days and up to two weeks of consistent use before their full benefit is felt, whilst topical preparations for skin conditions may begin to improve symptoms within one to two days. This is an important point for patients to understand, as stopping treatment prematurely may result in a return of symptoms.

It is important to note that corticosteroids are not a treatment for anaphylaxis. If a severe allergic reaction occurs — including breathing difficulty, throat swelling, or collapse — intramuscular adrenaline and emergency medical care are required immediately. Corticosteroids used for allergies are also entirely distinct from anabolic steroids, which are associated with performance enhancement and carry a very different risk profile. Corticosteroids prescribed for allergic conditions are well-established medicines regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and recommended within clinical guidelines issued by the National Institute for Health and Care Excellence (NICE).

Types of steroid treatments available for allergies in the UK

In the UK, steroid medication for allergies is available in several formulations, each suited to different conditions and routes of administration. The most commonly used forms include:

• Intranasal corticosteroid sprays (e.g., beclometasone, fluticasone, mometasone): Recommended by NICE and the British Society for Allergy and Clinical Immunology (BSACI) as first-line treatment for persistent or moderate-to-severe allergic rhinitis (hay fever). For mild or intermittent symptoms, a non-sedating antihistamine may be tried first. Intranasal sprays are available both on prescription and over the counter at pharmacies; many OTC products are licensed for adults aged 18 years and over, so patients should follow pack instructions or seek pharmacist advice regarding suitability for younger individuals.

• Topical corticosteroid creams and ointments (e.g., hydrocortisone, betamethasone): Used to manage allergic skin conditions such as eczema and contact dermatitis. They are classified by potency — from mild (hydrocortisone 1%) to very potent (clobetasol propionate) — and should be selected based on the severity and location of the skin condition. Regular use of emollients alongside topical steroids is recommended; emollients should generally be applied before the steroid preparation, leaving a short interval between applications.

• Corticosteroid eye drops (e.g., prednisolone eye drops): Occasionally used for allergic conjunctivitis that has not responded to antihistamine drops. Due to the risks of raised intraocular pressure, cataract formation, and worsening of undiagnosed eye infections, these should be initiated and monitored by an ophthalmologist rather than started in primary care.

• Oral corticosteroids (e.g., prednisolone tablets): Reserved for severe or acute allergic episodes, such as a significant flare of asthma or angioedema. They are generally prescribed for short courses only.

• Inhaled corticosteroids (e.g., beclometasone, budesonide): A cornerstone of asthma management in the UK, helping to reduce airway inflammation associated with allergic asthma.

• Combined intranasal steroid/antihistamine sprays (e.g., azelastine with fluticasone): An option when either treatment alone provides insufficient relief for allergic rhinitis.

Patients should be aware that depot intramuscular corticosteroid injections are not recommended for the treatment of hay fever in the UK, as UK guidance advises against their use due to the risk of systemic adverse effects.

The MHRA is responsible for licensing medicines in Great Britain, ensuring their safety and efficacy profiles are rigorously evaluated before they reach patients. (Northern Ireland follows EU pharmacovigilance arrangements under the UK–EU Withdrawal Agreement.)

How to use steroid medication safely and effectively

Using steroid medication correctly is essential to maximising its benefits whilst minimising potential risks.

For intranasal sprays, patients should shake the bottle before use, tilt the head slightly forward, and direct the nozzle away from the nasal septum to reduce the risk of irritation, nosebleeds, and, with prolonged incorrect technique, the rare risk of nasal septal perforation. Consistent daily use — even when symptoms appear to have settled — is important for maintaining the anti-inflammatory effect, particularly during high-pollen seasons.

For inhaled corticosteroids, patients using a pressurised metered-dose inhaler (pMDI) should use a spacer device to improve drug delivery and reduce local side effects. After each dose, rinsing the mouth with water and spitting out — or gargling — significantly reduces the risk of oral thrush (candidiasis) and hoarseness. In children on long-term inhaled corticosteroids, periodic monitoring of height is recommended, as a small, dose-related reduction in growth velocity has been observed.

For topical corticosteroid creams and ointments, the fingertip unit (FTU) is a helpful guide for applying the correct amount. One FTU — the amount squeezed from the tip of an adult finger to the first crease — covers an area roughly equivalent to two adult palms. Patients should apply the preparation thinly to affected areas only, avoid using potent preparations on the face or skin folds unless specifically directed by a clinician, and not use them for longer than the recommended duration without medical review. Potent and very potent topical steroids should generally be used for the shortest effective period.

When taking oral corticosteroids, it is important to:

• Take the medication in the morning with food to reduce the risk of stomach upset and to align with the body's natural cortisol rhythm

• Never stop a course abruptly if it has lasted more than a few weeks, as this can cause adrenal insufficiency — always follow the prescriber's tapering instructions

• Carry an NHS Steroid Emergency Card if on systemic steroids for three weeks or more, on repeated courses, or if there is a risk of adrenal suppression from high-dose inhaled or topical use — as recommended by MHRA and NHS guidance

Patients should inform their GP or pharmacist of all other medicines they are taking, as corticosteroids can interact with several drugs. Key interactions include:

• NSAIDs (increased risk of gastrointestinal bleeding)

• Anticoagulants such as warfarin (INR may be altered)

• Antidiabetic medicines (corticosteroids can raise blood glucose)

• Strong CYP3A inhibitors such as ritonavir, cobicistat, and itraconazole (can significantly increase systemic corticosteroid exposure even with inhaled or intranasal preparations, raising the risk of systemic side effects including adrenal suppression)

Live vaccines (such as yellow fever or live attenuated influenza vaccine) may be contraindicated in patients taking high-dose systemic corticosteroids; patients should seek advice from their GP or pharmacist before receiving any vaccination.

Pregnant or breastfeeding women should seek specific medical advice before using any steroid medication for allergies.

Possible side effects and what to watch for

The side effect profile of corticosteroids varies considerably depending on the formulation, potency, dose, and duration of use. When used correctly, many topical and inhaled preparations carry a low risk of systemic side effects because only a small amount of the medicine is absorbed into the bloodstream.

Common side effects by formulation include:

• Intranasal sprays: Nasal dryness, mild nosebleeds, and an unpleasant taste or smell. These are usually mild and often resolve with continued use or by adjusting technique. Rarely, prolonged incorrect use can cause nasal septal perforation.

• Topical creams and ointments: Skin thinning (atrophy), stretch marks, and increased skin fragility with prolonged use, particularly with potent preparations. Perioral dermatitis can occur if creams are used inappropriately on the face.

• Inhaled corticosteroids: Oral thrush (candidiasis) and hoarseness. Rinsing the mouth with water and spitting out after each use significantly reduces this risk. In children, long-term use at higher doses may be associated with a small reduction in growth velocity; height should be monitored periodically.

• Oral corticosteroids: Short courses are generally well tolerated for most people. Longer-term use or repeated courses can lead to weight gain, mood changes (including low mood, anxiety, or, rarely, more significant psychiatric effects), raised blood glucose, increased susceptibility to infections, osteoporosis, and adrenal suppression. Risks increase with higher doses and longer duration of use.

• Corticosteroid eye drops: Raised intraocular pressure, cataract formation, and worsening of undiagnosed eye infections are recognised risks with ocular steroid preparations.

Patients should seek urgent medical attention if they experience any of the following:

• Symptoms of anaphylaxis, including breathing difficulty, throat swelling, or wheeze — call 999 immediately

• Severe asthma symptoms that are not responding to a reliever inhaler — seek emergency care

• Severe eye pain or sudden changes in vision, which may indicate raised intraocular pressure or another serious eye condition

• Signs of infection (fever, increased redness, or pus) in an area being treated with topical steroids

Patients should contact their GP promptly if they experience:

• Significant mood changes, confusion, or unusual behaviour whilst taking oral steroids

• Symptoms of adrenal insufficiency such as persistent fatigue, dizziness, or nausea after stopping or reducing oral steroids

Short courses of corticosteroids are unlikely to cause serious long-term effects for the majority of people; however, risks rise with higher doses, longer duration, and repeated courses. Any concerns about side effects should always be discussed with a healthcare professional. NICE and NHS guidance both emphasise that the benefits of appropriately prescribed steroid medication for allergies generally outweigh the risks when used as directed.

Patients are encouraged to report any suspected side effects from medicines — including corticosteroids — via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk).

Frequently Asked Questions